rosiglitazone has been researched along with Macular Edema in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al Shaar, L; Azar, S; Bashshur, ZF; El-Mollayess, GM; Salti, HI | 1 |
| Aiello, LP; Child, A; Folkman, J; Shen, LQ; Weber, GM | 1 |
| Beare, N; Broadbent, DM; Kumar, N; Liazos, E | 1 |
| Contreras, R; Fong, DS | 1 |
| Booth, A; Konstantinidis, A; Lambley, RG; Vahdani, K | 1 |
| Chu, SH; Chun, SH; Li, AH | 1 |
| Guagnini, AP; Hautenauven, F; Lekeu Hinostroza, JP; Nyssen, V | 1 |
| Asensio-Sánchez, MJ; Asensio-Sánchez, VM; Gómez-Ramírez, V | 1 |
| Biagi, C; Marchesini, G; Marra, A; Motola, D; Piccinni, C; Poluzzi, E; Raschi, E | 1 |
| Donnelly, R; Idris, I; Warren, G | 1 |
| Colucciello, M | 1 |
| Arrigoni, F; Costanza, F; Di Blasi, P; Longobardi, A; Merante, D; Tatti, P | 1 |
13 other study(ies) available for rosiglitazone and Macular Edema
| Article | Year |
|---|---|
Impact of thiazolidinediones on macular thickness and volume in diabetic eyes.
Topics: Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Macular Edema; Male; Middle Aged; Pilot Projects; Pioglitazone; Prospective Studies; Retina; Rosiglitazone; Subretinal Fluid; Thiazolidinediones; Tomography, Optical Coherence; Visual Acuity | 2013 |
Rosiglitazone and delayed onset of proliferative diabetic retinopathy.
Topics: Aged; Angiogenesis Inhibitors; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Female; Humans; Hypoglycemic Agents; Longitudinal Studies; Macular Edema; Male; Medical Records; Middle Aged; PPAR gamma; Retrospective Studies; Risk Reduction Behavior; Rosiglitazone; Thiazolidinediones; Visual Acuity | 2008 |
Spontaneous resolution of diabetic macular oedema after discontinuation of thiazolidenediones.
Topics: Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Hypoglycemic Agents; Macular Edema; Male; Middle Aged; Remission, Spontaneous; Rosiglitazone; Thiazolidinediones; Visual Acuity | 2008 |
Glitazone use associated with diabetic macular edema.
Topics: Adult; Databases, Factual; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incidence; Macular Edema; Middle Aged; Pioglitazone; PPAR gamma; Prospective Studies; Risk Factors; Rosiglitazone; Thiazolidinediones | 2009 |
Rosiglitazone and pioglitazone. Beware macular oedema.
Topics: Diabetic Angiopathies; Diabetic Nephropathies; Heart Failure; Humans; Hypoglycemic Agents; Macular Edema; Pioglitazone; Rosiglitazone; Thiazolidinediones | 2009 |
Association of proliferative diabetic retinopathy with insulin use and microalbuminuria.
Topics: Albuminuria; Angiogenesis Inhibitors; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Humans; Hypoglycemic Agents; Insulin; Macular Edema; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2010 |
[Diabetic edematous maculopathy associated with rosiglitazone treatment: report of a case].
Topics: Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Humans; Hypoglycemic Agents; Macular Edema; Middle Aged; Rosiglitazone; Thiazolidinediones | 2009 |
Macular oedema linked to latanoprost and rosiglitazone.
Topics: Antihypertensive Agents; Humans; Hypoglycemic Agents; Latanoprost; Macular Edema; Prostaglandins F, Synthetic; Rosiglitazone; Thiazolidinediones | 2010 |
[Macular oedema due to rosiglitazone treatment in diabetes mellitus].
Topics: Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Macular Edema; Middle Aged; Rosiglitazone; Thiazolidinediones | 2010 |
Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system database.
Topics: Adverse Drug Reaction Reporting Systems; Bone and Bones; Cardiovascular System; Clinical Trials as Topic; Databases, Factual; Eye; Female; Fractures, Bone; Humans; Hypoglycemic Agents; Macular Edema; Male; Meta-Analysis as Topic; Myocardial Infarction; Odds Ratio; Pioglitazone; Risk; Rosiglitazone; Thiazolidinediones; United States; United States Food and Drug Administration | 2012 |
Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Incidence; Kaplan-Meier Estimate; Logistic Models; Macular Edema; Male; Middle Aged; Odds Ratio; Pioglitazone; PPAR gamma; Retrospective Studies; Risk Assessment; Rosiglitazone; Thiazolidinediones | 2012 |
Vision loss due to macular edema induced by rosiglitazone treatment of diabetes mellitus.
Topics: Diabetes Mellitus, Type 2; Fluorescein Angiography; Humans; Hypoglycemic Agents; Macular Edema; Male; Middle Aged; Rosiglitazone; Thiazolidinediones; Vision Disorders | 2005 |
Retrospective analysis of rosiglitazone and macular oedema in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Color Perception Tests; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fundus Oculi; Humans; Hypoglycemic Agents; Macular Edema; Male; Middle Aged; Retina; Retrospective Studies; Rosiglitazone; Thiazolidinediones; Vision Tests; Visual Acuity | 2008 |